Navigating the Asia-Pacific generic drug market involves grappling with regulatory requirements and overcoming diverse challenges. Stakeholders navigate a dynamic landscape, from strict safety standards to complex supply chains and pricing pressures, demanding adaptability and strategic maneuvering for success. Generic drugs surge globally for their cost-effectiveness, bioequivalence to brand-name counterparts, and adherence to stringent safety, efficacy, […]

Read More →